Safety and efficacy of an interleukin 12/23 inhibitor in a patient with constitutional neutropenia and psoriasis vulgaris.

An Bras Dermatol

General Dermatology and Severe Psoriasis Outpatient Clinic, Complexo Hospitalar Padre Bento de Guarulhos, Guarulhos, SP, Brazil.

Published: January 2022

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790215	PMC
http://dx.doi.org/10.1016/j.abd.2020.11.010	DOI Listing

Publication Analysis

safety efficacy

efficacy interleukin

interleukin 12/23

12/23 inhibitor

inhibitor patient

patient constitutional

constitutional neutropenia

neutropenia psoriasis

psoriasis vulgaris

safety

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!